The heterogeneity of sprout inhibitor application with chlorpropham.
The CIPC or chlorpropham is used on potatoes as "sprouting inhibitor". These lasts years, some set of belgian potatoes treated by CIPC exceeded the Maximum Residue Limit (MRL), fixed at 5 mg/kg. The heterogeneity of sprout inhibitor application would be one of the causes of over-dosage. In order to estimate the distribution of CIPC between potatoes, according to the formulation used (DP, EC and HN), a research project financed by "le fond budgétaire des matières premieres" has been set up. In order to evaluate the distribution of CIPC into the pile of potatoes, the efficiency of the different formulations as well as the residues caused by their application on tubers, some tests have been placed in the storage hall. These tests consist in taking off some samples at different places into the pile of potatoes during storage and destocking. The content of CIPC is analysed by capillary gas chromatography with detection by mass spectrometry detection (GC-MS) or nitrogen specific detection (GC- NPD). To estimate the efficiency, the sprouting are observed every month and samples of potatoes are taken off on the top of the pile to control the evolution of CIPC content. Considering the results of the tests, the inhibitor treatment with the formulation DP+HN seems to be the more efficient. As for the residues, the formulation DP leads to a higher content of CIPC than HN, that has a very low concentration. After treatment, the quantity really applied on tubers depends on the formulation used. In fact, 50% of CIPC applied by DP formulation are found on tubers but hardly 10%, after gas application.[1]References
- The heterogeneity of sprout inhibitor application with chlorpropham. Noël, S., Huyghebaert, B., Pigeon, O., Weickmans, B., Mostade, O. Communications in agricultural and applied biological sciences. (2003) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg
